Endocrine & Diabetic Complications

Research & Advanced Technologies

The metabolism of T3 and T4 combination therapy into active and inactive intermediates involves the action of 3 types of deiodinases. Recent studies of common genetic variations in deiodinase and thyroid hormone transport proteins offer fresh insights in understanding the variable response to thyroid hormone therapy and future research may clarify whether subsets of patients will benefit from challenges and improvements to combination therapy. Despite significant challenges, opportunities abound for improving the Thyroid Treatment Augments Psychiatric Therapy and also Improvements of Reproductive, Neuro-endocrinology or Neuroendocrine Function in Hypothalamic.